Evaluation of Metabolic and Cardiovascular Risk Measured by Laboratory Biomarkers and Cardiopulmonary Exercise Test in Children and Adolescents Recovered from Brain Tumors: The CARMEP Study
Authors:
- Alberto RomanoARAlberto Romano
- Fabrizio SollazzoFSFabrizio Sollazzo
- Serena RivettiSRSerena Rivetti
- Lorenzo MorraLMLorenzo Morra
- Tiziana ServideiTSTiziana Servidei
- Donatella LucchettiDLDonatella Lucchetti
- Giorgio AttinàGiorgio Attinà
- Palma MauriziPMPalma Maurizi
- Stefano MastrangeloSMStefano Mastrangelo
- Isabella Carlotta ZovattoIsabella Carlotta Zovatto
- Riccardo MontiRMRiccardo Monti
- Massimiliano BiancoMBMassimiliano Bianco
Open Access
Abstract
In recent decades, the improvement of treatments and the adoption of therapeutic protocols of international cooperation has led to an improvement in the survival of children affected by brain tumors. However, in parallel with the increase in survival, long-term side effects related to treatments have been observed over time, including the activation of chronic inflammatory processes and metabolic alterations, which can facilitate the onset of metabolic syndrome and increased cardiovascular risk. The aim of this study was to find possible statistically significant differences in the serum concentrations of early biomarkers of metabolic syndrome and in the results of cardiopulmonary exercise testing between survivors of childhood brain tumors and healthy controls. This is a prospective and observational study conducted on a group of 14 male patients who survived childhood brain tumors compared with the same number of healthy controls. The concentrations of early metabolic syndrome biomarkers [adiponectin, leptin, TNF-α, IL-1, IL-6, IL-10, endothelin-1, apolipoprotein B, and lipoprotein (a)] were measured and a cardiopulmonary exercise test (CPET) was performed. Results: Childhood brain tumor survivors performed worse on average than controls on the CPET. Furthermore, they showed higher endothelin-1 values than controls (p = 0.025). The CPET results showed an inverse correlation with leptin. The differences found highlight the greater cardiovascular risk of brain tumor survivors, and radiotherapy could be implicated in the genesis of this greater cardiovascular risk.Keywords
This publication has 65 references indexed in Scilit:
- Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence StudyJournal of Diabetes Research, 2013
- After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhoodFrontiers in Pharmacology, 2013
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic TherapyJournal of Clinical Oncology, 2012
- Cardiovascular Risk and Insulin Resistance in Childhood Cancer SurvivorsThe Journal of Pediatrics, 2012
- Enhanced endothelin-1 system activity with overweight and obesityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Basal and Exercise-Induced Regulation of Skeletal Muscle CapillarizationExercise and Sport Sciences Reviews, 2009
- Candida parapsilosis Bloodstream Infection in Pediatric Oncology Patients: Results of an Epidemiologic InvestigationInfection Control & Hospital Epidemiology, 2004
- From Fat Fighter to Risk FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Role of endothelin in human hypertensionCanadian Journal of Physiology and Pharmacology, 2003
- Contribution of androgens to the gender difference in leptin production in obese children and adolescents.Journal of Clinical Investigation, 1997